Description
An inhibitor of MAO-B (IC50 = 4.43 nM for rat brain enzyme); selective for MAO-B over MAO-A (IC50 = 412 nM for rat brain enzyme); inhibits rat brain MAO-B in vivo (ED50 = 0.1 mg/kg); reduces cerebral edema in a mouse model of traumatic brain injury; reduces cortical and hippocampal levels of full-length and soluble APP in rats and mice at 0.1 mg/kg; reduces α-synuclein-induced substantia nigral neuron loss and improves motor dysfunction in a mouse model of Parkinson’s disease
Formal name: (1R)-2,3-dihydro-N-2-propyn-1-yl-1H-inden-1-amine
Synonyms: (R)-(+)-Rasagiline
Molecular weight: 171.2
CAS: 136236-51-6
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cell Biology|Cell Death|Apoptosis||Research Area|Neuroscience|Neurodegenerative Disorders|Alzheimer’s Disease||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease||Research Area|Neuroscience|Neuroprotection